To test this hypothesis, we used two independent breast cancer cell lines that carry FBW7 loss (Hs-578T and MDA-MB-231) and restored FBW7 protein function by using exogenous tagged FBW7. This evidence concerns the gene FBXW7 and breast carcinoma.